Novel plasma biomarkers improve discrimination of metabolic health independent of weight
暂无分享,去创建一个
Nathan A. Bihlmeyer | Neha J. Pagidipati | W. Kraus | J. Bain | N. Pagidipati | N. Bihlmeyer | L. Kwee | R. McGarrah | Svati H. Shah | Stephen P Ellison | Jawan W Abdulrahim | S. Shah | Robert W. McGarrah | Jawan W. Abdulrahim | Neha J. Pagidipati
[1] L. Shaw,et al. ASSOCIATION OF ABNORMAL ELECTROCARDIOGRAPHY RESPONSE ON STRESS ECHOCARDIOGRAM WITH MAJOR ADVERSE CARDIOVASCULAR EVENTS IN WOMEN: A REPORT FROM THE WOMEN’S ISCHEMIA SYNDROME EVALUATION (WISE) STUDY , 2021 .
[2] Chun-Chin Chang,et al. Lipid paradox in patients with acute myocardial infarction: Potential impact of malnutrition. , 2019, Clinical nutrition.
[3] Francesca N. Delling,et al. Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association , 2018, Circulation.
[4] E. Braunwald,et al. Metabolic syndrome and the risk of adverse cardiovascular events after an acute coronary syndrome , 2018, European journal of preventive cardiology.
[5] M. Delgado-Rodríguez,et al. Systematic review and meta-analysis. , 2017, Medicina intensiva.
[6] W. Kraus,et al. Sildenafil Treatment in Heart Failure With Preserved Ejection Fraction: Targeted Metabolomic Profiling in the RELAX Trial , 2017, JAMA cardiology.
[7] C. Hennekens,et al. Metabolic Syndrome , 2017, Journal of cardiovascular pharmacology and therapeutics.
[8] F. Magkos,et al. Lean, but not healthy: the ‘metabolically obese, normal-weight’ phenotype , 2016, Current opinion in clinical nutrition and metabolic care.
[9] D. Jacobs,et al. Comparison of the Predictive Value of GlycA and Other Biomarkers of Inflammation for Total Death, Incident Cardiovascular Events, Noncardiovascular and Noncancer Inflammatory-Related Events, and Total Cancer Events. , 2016, Clinical chemistry.
[10] P. Ridker,et al. Circulating N-Linked Glycoprotein Acetyls and Longitudinal Mortality Risk. , 2016, Circulation research.
[11] W. Kraus,et al. High-density lipoprotein subclass measurements improve mortality risk prediction, discrimination and reclassification in a cardiac catheterization cohort. , 2016, Atherosclerosis.
[12] W. Kraus,et al. Metabolomic Quantitative Trait Loci (mQTL) Mapping Implicates the Ubiquitin Proteasome System in Cardiovascular Disease Pathogenesis , 2015, PLoS genetics.
[13] Daniel S. Berman,et al. Is Metabolic Syndrome Predictive of Prevalence, Extent, and Risk of Coronary Artery Disease beyond Its Components? Results from the Multinational Coronary CT Angiography Evaluation for Clinical Outcome: An International Multicenter Registry (CONFIRM) , 2015, PloS one.
[14] W. French,et al. Relationship between serum low-density lipoprotein cholesterol and in-hospital mortality following acute myocardial infarction (the lipid paradox). , 2015, The American journal of cardiology.
[15] Xuefeng Yu,et al. Lipid accumulation product and visceral adiposity index are effective markers for identifying the metabolically obese normal-weight phenotype , 2015, Acta Diabetologica.
[16] M. Connelly,et al. Lipoprotein insulin resistance index: a lipoprotein particle-derived measure of insulin resistance. , 2014, Metabolic syndrome and related disorders.
[17] D. Rader,et al. HDL and cardiovascular disease , 2014, The Lancet.
[18] Bryan C. Batch,et al. Branched chain amino acids are novel biomarkers for discrimination of metabolic wellness. , 2013, Metabolism: clinical and experimental.
[19] B. Cheung,et al. Management of obesity in the National Health and Nutrition Examination Survey (NHANES), 2007-2008. , 2012, Annals of epidemiology.
[20] W. Kraus,et al. Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease. , 2012, American heart journal.
[21] W. Kraus,et al. Metabolic profiles predict adverse events after coronary artery bypass grafting. , 2012, The Journal of thoracic and cardiovascular surgery.
[22] W. Kraus,et al. Reclassification of cardiovascular risk using integrated clinical and molecular biosignatures: Design of and rationale for the Measurement to Understand the Reclassification of Disease of Cabarrus and Kannapolis (MURDOCK) Horizon 1 Cardiovascular Disease Study. , 2010, American heart journal.
[23] Geoffrey S Ginsburg,et al. Association of a Peripheral Blood Metabolic Profile With Coronary Artery Disease and Risk of Subsequent Cardiovascular Events , 2010, Circulation. Cardiovascular genetics.
[24] Wei Zhang,et al. The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis , 2009, BMC public health.
[25] K. Reynolds,et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). , 2008, Archives of internal medicine.
[26] Dana Dabelea,et al. The metabolic syndrome. , 2008, Endocrine reviews.
[27] H. Bloomfield,et al. Low-Density Lipoprotein and High-Density Lipoprotein Particle Subclasses Predict Coronary Events and Are Favorably Changed by Gemfibrozil Therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial , 2006, Circulation.
[28] Nathan D. Wong,et al. Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults , 2004, Circulation.
[29] S. Reis,et al. Clinical Importance of Obesity Versus the Metabolic Syndrome in Cardiovascular Risk in Women: A Report From the Women’s Ischemia Syndrome Evaluation (WISE) Study , 2004, Circulation.
[30] S. Anker,et al. The relationship between cholesterol and survival in patients with chronic heart failure. , 2003, Journal of the American College of Cardiology.
[31] G. Fonarow,et al. Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure. , 2002, Journal of cardiac failure.
[32] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[33] Scott B. Crown,et al. Cardiovascular Metabolomics , 2018, Circulation research.
[34] Jacob P. Kelly,et al. A Novel Protein Glycan-Derived Inflammation Biomarker Independently Predicts Cardiovascular Disease and Modifies the Association of HDL Subclasses with Mortality. , 2017, Clinical chemistry.
[35] M. Biddle,et al. A report from the American Heart Association Council on Cardiovascular and Stroke Nursing. , 2015, The Journal of cardiovascular nursing.
[36] W. Kraus,et al. Validation of the association between a branched chain amino acid metabolite profile and extremes of coronary artery disease in patients referred for cardiac catheterization. , 2014, Atherosclerosis.
[37] H. Minuk,et al. Metabolic syndrome. , 2005, Journal of insurance medicine.
[38] J. Otvos,et al. Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy. , 2002, Clinical laboratory.
[39] J. Mckenney,et al. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.